Fund moves
5 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PRVA · NASDAQ · Health Care Services
Privia Health Group, Inc. (PRVA) · oqro.io/stocks/PRVA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$24.55+0.88 (+3.72%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
+3.4% (+$0.80) from Nov 13, 2025 to Nov 13, 2026 · adjusted daily closes
Adjusted close went from $23.75 on Nov 13, 2025 to $24.55 on Nov 13, 2026 (+3.4%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 6 13F position changes for 3 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Services company based in Arlington County, Virginia.
Last 12 months
+3.4%
Market value
$3.14B
S&P 500 +12.3% over the same dates. Prices adjusted for splits and dividends.
Short interest: 3.9M shares sold short (3.1% of shares outstanding), −22.2% vs the previous count, 4.5 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$657M
+13.2% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $446M, at Sep 30, 2026
Net income, last 12 months
$34.8M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 5, 2026.
Revenue, fiscal 2025
$2.12B
+22.3% vs the year before
Net income, fiscal 2025
$22.9M
As reported in the annual filing
Shares outstanding
128M
As of Oct 30, 2026
Fund moves
5 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
3 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 15, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
5 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
5 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
No open-market purchase by an insider of Privia Health Group, Inc. was filed in the last 90 days. The latest on record was on Jun 11, 2024.
Since 2021, Privia Health Group, Inc. insiders reported 19 open-market purchases and 328 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2024.
No open-market sale by an insider of Privia Health Group, Inc. (PRVA) was filed with the SEC in the last 90 days.
No trade in Privia Health Group, Inc. (PRVA) was disclosed by a member of Congress in the last 12 months.
Privia Health Group, Inc.'s next results are expected on Feb 24, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
0 certified in FY2026 Q3, vs 0 a year earlier.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Against the S&P 500 over the year
Since Nov 11, 2025, PRVA is up 0.9% and the index fund is up 10.4%: 10 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much PRVA moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
Insiders of Privia Health Group, Inc. reported 19 open-market purchases and 328 sales since 2021; purchases in 2 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $5.51M16×16 trades |
| 2024 | $9.31M7×7 trades | $4.08M13×13 trades |
| 2023 | — | $2.04B99×99 trades |
| 2022 | — | $413M162×162 trades |
| 2021 | $696K12×12 trades | $2.11B38×38 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Vanguard Capital Management
Schedule 13G: passive · filed Oct 30, 2026 · 6.51M shares
FMR LLC
Schedule 13G: passive · filed Oct 7, 2026 · 6.39M shares
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Last results
Nov 5, 2026
Within the 30 days after it, until Dec 5, 2026
Next results, expected
Feb 24, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Privia Health Group, Inc.'s own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Privia Health Group, Inc.'s policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.